US$ 21.33
canada generic semaglutide approves from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Hims Inc. - Hims &
Description
But one consequence that catches many patients off guard is what happens to their skin.

Canada is about to become ground zero for a pharma revolution

In India, the patent for semaglutide expires in March 2026, and at least 15 drugmakers are in the fray to tap the opportunity
Boost metabolism and achieve your goals faster!

Semaglutide dosing frequency directly impacts weight loss outcomes and tolerability

Ready to take the next step to achieve your weight loss goals